Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012791) titled 'Phase 1 Clinical Trial for the Pharmacokinetic and Safety Evaluation of Ojeoksan and Three Drugs' on Oct. 19.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: Bundang CHA General Hospital
Condition:
Diseases of the musculoskeletal system and connective tissue
Intervention:
Drug : This study is an open-label, repeated-dose, Phase 1 clinical trial designed to evaluate the effects of Ojeok-san on the pharmacokinetic characteristics and safety of Dexibuprofen, Pelubiprofen, and Eperisone...